Check-Cap Ltd.
(CHEK)
undefined
undefined%
At close: undefined
0.63
0.00%
After-hours Dec 13, 2024, 03:24 PM EST
Company Description
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.
Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
The company was incorporated in 2004 and is based in Isfiya, Israel.
Check-Cap Ltd.
Country | IL |
IPO Date | Mar 4, 2015 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 85 |
CEO | Dr. Yoav Kimchy Ph.D. |
Contact Details
Address: Check-Cap Building Isfiya, IL | |
Website | https://www.check-cap.com |
Stock Details
Ticker Symbol | CHEK |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001610590 |
CUSIP Number | M2361E203 |
ISIN Number | IL0011336851 |
Employer ID | 00-0000000 |
SIC Code | 3844 |
Key Executives
Name | Position |
---|---|
David Benaim | Interim Chief Financial Officer |
Dr. Yoav Kimchy Ph.D. | Founder, Head of R&D and Member of Scientific Advisory Board |
Noa Reshef M.B.A. | Head of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 03, 2024 | 6-K | Filing |
Sep 13, 2024 | 6-K | Filing |
Aug 05, 2024 | 6-K | Filing |
May 15, 2024 | 20-F | Filing |
May 01, 2024 | NT 20-F | Filing |
Apr 29, 2024 | 6-K | Filing |
Apr 15, 2024 | 6-K | Filing |
Apr 10, 2024 | 6-K/A | [Amend] Filing |
Apr 08, 2024 | SC 13D/A | [Amend] Filing |
Apr 08, 2024 | 6-K | Filing |